SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 14, 1999
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission file Number) (IRS Identification
of incorporation) No.)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
Osteotech, Inc. has announced that GenSci Regeneration Laboratories Inc.
("GenSci") has made a motion in United States District Court for the Central
District of California to amend its patent infringement claims against Osteotech
to include Grafton(R) DBM Gel and Grafton(R) DBM Putty. Osteotech intends to ask
the court not to grant GenSci's motion.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: April 15, 1999
OSTEOTECH, INC.
---------------------------
(Registrant)
By: /s/ Michael J. Jeffries
--------------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Operating Officer and
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting Officer)
